Home Search
eoe - search results
If you're not happy with the results, please do another search
Company Completes Enrollment for Phase 2 Trial of “Immune Resetting” Peptide for Allergic Diseases
Topline data anticipated in Q2 2023.
Allakos Announces New Antibody that Prevents Anaphylaxis in Humanized Mice
Company will initiate human trials next year.
This Holiday Season, See the Potential Impact that Peanut Allergy Treatment Can Make
Did you know there’s a treatment option in addition to avoidance alone?
CHOP Receives $2M Philanthropic Gift to Launch Food Allergy Study Using Dupilumab
"A successful clinical trial would open the possibility of food introduction to more than 3,500 CHOP patients with EoE."
Notebooks, check. Backpack, check. Peanut allergy treatment, check.
What if you could give your child a treatment option, in addition to practicing a strict peanut-free diet?
Two UK Allergy Moms Who Suffered Horrific Losses Demand an Allergy Czar. We Should...
We applaud the efforts of Ms Ednan-Laperouse and Ms Turay and believe their concept of a single person responsible for the health and safety of the allergic community should be adopted here in the US.
How the First FDA-Approved Therapy for Peanut Allergy is Helping Families
What is PALFORZIA?
PALFORZIA is a treatment for people who are allergic to peanuts. PALFORZIA can help reduce the severity of allergic reactions, including anaphylaxis,...
Dupixent (dupilumab) Study Shows Significant Improvement in Eosinophilic Esophagitis Signs and Symptoms
Phase 3 trial in (EoE) to show a significantly improved structural and histologic measures, while rapidly improving ability to swallow in patients 12 years and older
The FASTER Act: What It Does and Why YOU Need to Help Pass It
FARE can't do it alone: Do your part to help pass the FASTER Act.
End Allergies Together, Responsible for Funding Important Research, is Winding Down Operations
"We are grateful to all of those who have supported us and helped E.A.T make such a significant impact on the food allergy industry."
Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.
We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.
Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.
Please see our Terms of Service and Privacy Policy.
Copyright ©2011-2024 SnackSafely.com, Inc — All rights reserved